Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 8.92 USD -9.9% Market Closed
Market Cap: 1B USD
Have any thoughts about
Applied Therapeutics Inc?
Write Note

Applied Therapeutics Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Applied Therapeutics Inc
Other Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Applied Therapeutics Inc
NASDAQ:APLT
Other Current Liabilities
$54.4m
CAGR 3-Years
349%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Current Liabilities
$11.7B
CAGR 3-Years
197%
CAGR 5-Years
551%
CAGR 10-Years
53%
Amgen Inc
NASDAQ:AMGN
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Liabilities
$357.6m
CAGR 3-Years
21%
CAGR 5-Years
36%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Liabilities
$627.2m
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
24%

See Also

What is Applied Therapeutics Inc's Other Current Liabilities?
Other Current Liabilities
54.4m USD

Based on the financial report for Dec 31, 2023, Applied Therapeutics Inc's Other Current Liabilities amounts to 54.4m USD.

What is Applied Therapeutics Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 3Y
349%

Over the last year, the Other Current Liabilities growth was 297%. The average annual Other Current Liabilities growth rates for Applied Therapeutics Inc have been 349% over the past three years .

Back to Top